Why the study?
The study aimed to assess perceptions, motivations, and barriers to treatment adherence according to emotional, lifestyle, medical, and non-adherence risk profiles in patients with hypertension.
Population
2615 treated hypertensive patients (≥18 years of age) from 5 European countries
Comparison
Patients with low/middle risk vs high risk of non-adherence
Design
Cross-sectional online survey
Authors
Loading...
Should not yet change practice; leaves open whether targeting emotions and stress improves antihypertensive adherence.
Emotional factors, stress, and family hardships are significant, underrecognized drivers of non-adherence to antihypertensive therapy, highlighting the need for better patient-physician communication.
Burnier et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: